LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.94 | 771.67 | 1007 | 1045 | 0.9635 | 0.8372 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.94 | 771.67 | 1167 | 1045 | 1.1166 | 1.5733 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 9.16 | 771.67 | 1089 | 1138 | 0.9565 | 0.8477 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 9.16 | 771.67 | 1231 | 1138 | 1.0812 | 1.2988 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 11.56 | 771.67 | 1203 | 1280 | 0.9394 | 0.8360 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 11.56 | 771.67 | 1425 | 1280 | 1.1127 | 1.3148 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 13.78 | 771.67 | 1388 | 1459 | 0.9509 | 0.8933 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 13.78 | 771.67 | 1605 | 1459 | 1.0995 | 1.2173 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.00 | 771.67 | 1554 | 1585 | 0.9801 | 0.9617 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.00 | 771.67 | 1772 | 1585 | 1.1176 | 1.2260 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.22 | 771.67 | 1695 | 1741 | 0.9734 | 0.9546 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.22 | 771.67 | 1907 | 1741 | 1.0951 | 1.1609 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.44 | 771.67 | 1832 | 1910 | 0.9587 | 0.9366 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 20.44 | 771.67 | 2069 | 1910 | 1.0828 | 1.1253 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.66 | 771.67 | 2051 | 2141 | 0.9577 | 0.9422 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 22.66 | 771.67 | 2353 | 2141 | 1.0988 | 1.1321 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.89 | 771.67 | 2296 | 2397 | 0.9576 | 0.9477 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.89 | 771.67 | 2671 | 2397 | 1.1140 | 1.1364 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.11 | 771.67 | 2565 | 2675 | 0.9588 | 0.9537 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.11 | 771.67 | 2933 | 2675 | 1.0964 | 1.1053 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.33 | 771.67 | 2848 | 2939 | 0.9689 | 0.9675 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.33 | 771.67 | 3222 | 2939 | 1.0962 | 1.0975 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.55 | 771.67 | 3096 | 3196 | 0.9685 | 0.9690 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.55 | 771.67 | 3506 | 3196 | 1.0967 | 1.0921 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.78 | 771.67 | 3336 | 3499 | 0.9532 | 0.9566 | MN20160304_L01 | D09 |